Tim Cooksley completed his foundation training at Whiston Hospital, UK, between 2005 and 2007, followed by core medical training and higher specialist training in acute medicine in the North West of England, which he completed in 2013. He subsequently became a Consultant in Acute Medicine at the University Hospital of South Manchester, now part of Manchester University NHS Foundation Trust.
Since 2014, he has been affiliated with The Christie NHS Foundation Trust in Manchester, where he currently serves as Consultant in Acute Medicine and Clinical Director in Acute Oncology. He has played a leading role in developing acute medical services for patients with cancer, particularly in the management of oncological emergencies, treatment-related complications, and acute ambulatory cancer care.
His main clinical and research interests include acute medicine, acute oncology, risk stratification, patient safety, and the management of complications associated with cancer treatment. His recent work has focused particularly on immune checkpoint inhibitor-related toxicities, febrile neutropenia, and innovative models of ambulatory care. He has contributed to the development of national and international clinical guidelines and has participated in several collaborative research initiatives aimed at improving the quality and safety of acute medical care.
He has held several prominent national and international leadership positions, including President of the Society for Acute Medicine and National Clinical Advisor for Acute Medicine to the NHS England Getting It Right First Time (GIRFT) programme. He has also served on the Council of the Royal College of Physicians and contributed to national initiatives concerning the organization and delivery of urgent and emergency care.
Internationally, he has played an active role in the Multinational Association of Supportive Care in Cancer (MASCC), contributing to research and clinical guidance on neutropenia and immune checkpoint inhibitor toxicities. He was the first UK-based practising clinician to be awarded Fellowship of MASCC (FMASCC).
Alongside his clinical and research activities, he has been extensively involved in undergraduate and postgraduate medical education, clinical supervision, and the training of healthcare professionals. He has lectured at numerous national and international scientific meetings and contributed to research collaborations in acute medicine, acute oncology, and patient safety.